Hospital sewers may be breeding grounds for dangerous superbugs, study finds

Hospital Sewers May Foster Antibiotic‑Resistant Bacteria, Swedish Study Finds
A new study published in the peer‑reviewed journal Nature Communications suggests that wastewater from hospitals can create conditions that encourage the growth of antibiotic‑resistant bacteria, potentially turning sewer systems into hotspots for antimicrobial resistance. The research, conducted by a team of scientists from the University of Gothenburg in Sweden, examined water from ten hospitals and compared it with samples from eight municipal wastewater treatment plants.
The Experiment
To isolate the effect of hospital wastewater itself, the researchers first filtered samples to remove existing bacteria. They then exposed fresh, non‑resistant bacterial cultures to the filtered water in the laboratory. The team focused on Escherichia coli (E. coli), a common gut bacterium that can become pathogenic when it acquires resistance to certain antibiotics.
All ten hospital samples significantly promoted the growth of E. coli strains that were resistant to ciprofloxacin, a fluoroquinolone, and cefotaxime, a third‑generation cephalosporin. In contrast, none of the eight municipal wastewater samples produced the same effect. The difference points to the presence of specific substances in hospital sewage that support resistant bacteria.
In a parallel field test, plastic plates were inserted into active sewer pipes and left in place for 30 days. Bacteria that colonized the plates were roughly three times more likely to be resistant to the two antibiotics than bacteria found in the surrounding wastewater. This pattern was not seen in municipal sewers, reinforcing the idea that hospital systems provide a distinct environment conducive to resistance.
What Drives the Effect?
The researchers measured antibiotic concentrations in the wastewater and found that the levels of ciprofloxacin and, to a lesser extent, cefotaxime matched the concentrations that stimulated resistant E. coli growth in laboratory conditions. “Ciprofloxacin appears to be a major contributor,” said Joakim Larsson, professor of environmental pharmacology at the University of Gothenburg and director of the Centre for Antibiotic Resistance Research. “Cefotaxime also plays a role.”
Larsson explained that antibiotics taken by patients often pass through the body unchanged, entering hospital sewer systems and creating a selective environment in which bacteria that can withstand these drugs thrive.
Potential Public Health Implications
While the study did not directly link hospital wastewater to human infections, Larsson cautioned that resistant bacteria could potentially reach people through contaminated water. “When it rains heavily, treatment plants are typically overloaded and may release untreated or partially treated wastewater containing high levels of bacteria,” he said. “If people come into contact with such waters, they can acquire these bacteria and then spread them from person to person.”
The team acknowledged that the 30‑day experiment does not capture longer‑term dynamics, and that the findings may not apply to all bacterial species or to wastewater systems outside Sweden. Nonetheless, the researchers highlighted the importance of knowing where resistant bacteria are promoted versus where they are less likely to develop. This information could guide resource allocation and targeted interventions to curb antimicrobial resistance.
Possible Solutions
Larsson outlined two potential approaches to reduce the risk posed by hospital sewers:
Alternative Antibiotics: Using antibiotics that are less likely to appear unchanged in patients’ excreta could reduce the selective pressure in wastewater. However, the researchers noted that such alternatives must be equally effective and that patient treatment needs cannot be compromised.
On‑Site Wastewater Treatment: Treating wastewater at hospitals to remove antibiotics—particularly fluoroquinolones and beta‑lactams—could help eliminate the drivers of resistance. Existing technologies can remove these compounds, but they may be costly and require additional treatment steps. Treating wastewater at municipal plants, by contrast, may be less effective because the antibiotic concentrations there are lower.
“We believe that with more knowledge about the drivers, we can develop technical solutions that are targeted and hopefully less expensive,” Larsson said.
Context and Limitations
Antibiotic resistance remains a significant public health challenge. In the United States alone, the Centers for Disease Control and Prevention reported over 9.3 million drug‑resistant infections in 2026, resulting in more than 39,000 deaths. The study’s focus on E. coli and a limited set of antibiotics, along with the fact that all sampling sites were in Sweden, means the results may not generalize globally.
The researchers also did not determine whether the growth of resistant bacteria in hospital sewers translates into higher infection rates among patients or nearby communities. Further studies, including epidemiological investigations, will be needed to establish a direct link.
Next Steps
The University of Gothenburg team plans to expand their research to include other bacterial species and a broader range of antibiotics. They also intend to conduct long‑term field studies to assess how resistant bacteria spread beyond hospital sewers.
For now, the study underscores a potentially overlooked source of antimicrobial resistance and highlights the need for more comprehensive wastewater management strategies—especially in healthcare settings—to protect public health.


